Levofloxacine Noridem Enterprises

Levofloxacin, the active ingredient in Levofloxacine Noridem Enterprises, is a fluoroquinolone antibiotic presented as an intravenous solution for intravenous use. It treats a range of bacterial infections in adult patients. GNH USA supplies Levofloxacine Noridem Enterprises as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levofloxacin is a fluoroquinolone antibiotic used to treat infections caused by susceptible bacteria.

Community‑acquired pneumonia: achieves clinical cure and bacterial eradication in adults. Complicated urinary tract infections: resolves infection and prevents recurrence. Skin and soft tissue infections: promotes healing and eliminates pathogenic bacteria. Acute bacterial sinusitis: relieves symptoms and clears sinus infection. Acute bacterial exacerbation of chronic bronchitis: improves lung function and reduces bacterial load.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Rash - Insomnia

Serious or Rare Side Effects: - Tendon rupture or inflammation - QT interval prolongation and cardiac arrhythmias - Clostridioides difficile‑associated colitis - Peripheral neuropathy - Severe hypersensitivity reactions (e.g., Stevens‑Johnson syndrome) - Seizures or convulsions

Levofloxacin requires careful consideration of patient‑specific factors before use. - Renal impairment: adjust dose or monitor renal function. - Central nervous system effects: monitor for seizures, especially in patients with a history of epilepsy. - QT prolongation: avoid in patients with known cardiac arrhythmias or concurrent QT‑prolonging drugs. - Tendon injury: advise patients to report tendon pain or swelling promptly. - Pregnancy Category C: use only if potential benefit justifies the risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids, sucralfate, iron or zinc supplements: chelate the drug and markedly reduce absorption. - Warfarin: may increase anticoagulant effect and risk of bleeding. - Theophylline: concurrent use can raise theophylline plasma levels, increasing toxicity risk.

Moderate Interactions (Monitor Closely): - CYP1A2 substrates (e.g., caffeine, clozapine): may experience increased plasma concentrations. - Diabetes medications (insulin, oral hypoglycemics): monitor blood glucose as hypoglycemia may occur. - Other QT‑prolonging agents (e.g., macrolides, fluoroquinolones): assess cardiac risk and consider ECG monitoring.